Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


DH extends shortage protocol for fluoxetine 30mg and 40mg to November

The government is extending its serious shortage protocols (SSPs) for fluoxetine 30mg and 40mg capsules beyond tomorrow’s planned end date.

The SSP for fluoxetine 40mg capsules has been extended to November 11, while the protocol for fluoxetine 30mg capsules will continue until November 20, the Department of Health and Social Care (DH) announced this afternoon (October 30).

SSPs for both strengths were supposed to end tomorrow (October 31), but the DH is “varying” their end dates “due to ongoing supply issues with fluoxetine 30mg and 40mg capsules”, it told C+D.

The DH withdrew its SSP for fluoxetine 10mg capsules on October 25, after enough stocks of the 10mg strength were found to be “available to meet normal demand”.

What are the serious shortage protocols?

The SSPs for fluoxetine – the first, and so far only, SSPs to be announced – were issued by the DH on October 3, granting pharmacists the ability to supply an alternative strength or form of fluoxetine 10mg30mg or 40mg capsules, without contacting a patient’s GP first.

More information and supporting guidance on SSPs can be found on the NHS Business Services Authority’s website.

How have the fluoxetine shortages affected you?

Related Content


Pharmacist Manager
£30 per hour

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts